Guidelines on the Management of Common Bile Duct Stones

Total Page:16

File Type:pdf, Size:1020Kb

Guidelines on the Management of Common Bile Duct Stones Downloaded from http://gut.bmj.com/ on May 23, 2017 - Published by group.bmj.com Guidelines Updated guideline on the management of common bile duct stones (CBDS) Earl Williams,1 Ian Beckingham,2 Ghassan El Sayed,1 Kurinchi Gurusamy,3 Richard Sturgess,4 George Webster,5 Tudor Young6 1Bournemouth Digestive ABSTRACT suspicion remains high. (Low-quality evidence; Diseases Centre, Royal Common bile duct stones (CBDS) are estimated to be strong recommendation) Bournemouth and Christchurch – NHS Hospital Trust, present in 10 20% of individuals with symptomatic Bournemouth, UK gallstones. They can result in a number of health New 2016 2HPB Service, Nottingham problems, including pain, jaundice, infection and acute Magnetic resonance cholangiopancreatography University Hospitals NHS Trust, pancreatitis. A variety of imaging modalities can be (MRCP) and endoscopic ultrasound (EUS) are both Nottingham, UK 3 employed to identify the condition, while management recommended as highly accurate tests for identifying Department of Surgery, fi University College London of con rmed cases of CBDS may involve endoscopic CBDS among patients with an intermediate probabil- Medical School, London, UK retrograde cholangiopancreatography, surgery and ity of disease. MRCP predominates in this role, with 4Aintree Digestive Diseases radiological methods of stone extraction. Clinicians are choice between the two modalities determined by Unit, Aintree University Hospital therefore confronted with a number of potentially valid individual suitability, availability of the relevant test, Liverpool, Liverpool, UK 5Department of options to diagnose and treat individuals with suspected local expertise and patient acceptability. (Moderate Hepatopancreatobiliary CBDS. The British Society of Gastroenterology first quality evidence; strong recommendation) Medicine, University College published a guideline on the management of CBDS in Hospital, London, UK 2008. Since then a number of developments in New 2016 6Department of Radiology, The Princess of Wales Hospital, management have occurred along with further systematic It is suggested that patients with suspected CBDS Bridgend, UK reviews of the available evidence. The following who have not been previously investigated should recommendations reflect these changes and provide undergo USS and LFTs. For patients with an inter- Correspondence to updated guidance to healthcare professionals who are mediate probability of stones, MRCP or EUS is Dr Earl Williams, Digestive involved in the care of adult patients with suspected or recommended as a next step unless the patient is Diseases Centre, Royal proven CBDS. It is not a protocol and the proceeding directly to cholecystectomy supplemen- Bournemouth Hospital, Castle ted by intraoperative cholangiography (IOC) or Lane East, Bournemouth BH7 recommendations contained within should not replace 7DW, UK; earl.williams@rbch. individual clinical judgement. laparoscopic ultrasound (LUS). Endoscopic retro- nhs.uk grade cholangiopancreatography (ERCP) should be reserved for patients in whom preceding assessment Received 25 May 2016 SUMMARY OF RECOMMENDATIONS indicates a need for endoscopic therapy. (Low- Revised 8 December 2016 Where recommendations from the 2008 guide- quality evidence; weak recommendation) Accepted 15 December 2016 1 Published Online First lines are obsolete, they are omitted. Where recom- 25 January 2017 mendations are prefaced by ‘2008’ there has been Endoscopic management of CBDS no new evidence found since the last guideline and New 2016 no change in the recommendation; ‘2008, It is suggested that the British Society of amended 2016’ indicates that while no new evi- Gastroenterology (BSG) national standards frame- dence has been found since the last guideline there work for ERCP is implemented by service providers. has been a change in wording that effects the (Very low-quality evidence; weak recommendation) meaning of the recommendation; ‘2016’ indicates that new evidence has been found and no change New 2016 in the recommendation is necessary; ‘New 2016’ For selected patients, tolerability and likelihood of indicates that new evidence has resulted in a new therapeutic success is higher if ERCP is performed or amended recommendation. with propofol sedation or general anaesthesia. It is recommended that hospitals looking after patients General principles in management of common with CBDS should have ready and prompt access bile duct stones to anaesthesia supported ERCP. This can be an New 2016 on-site service or provided by another ERCP unit It is recommended that patients diagnosed with as part of a clinical network. (Low-quality evi- common bile duct stones (CBDS) are offered stone dence; strong recommendation) extraction if possible. Evidence of benefit is greatest for symptomatic patients. (Low-quality evidence; 2008 strong recommendation) It is suggested that patients should be managed in accordance with the BSG guidelines on antibiotic Identifying individuals with CBDS prophylaxis during endoscopy. (Very low-quality New 2016 evidence; weak recommendation) Trans-abdominal ultrasound scanning (USS) and To cite: Williams E, liver function tests (LFTs) are recommended for New 2016 Beckingham I, El Sayed G, patients with suspected CBDS. Normal results do To reduce the risk of post-ERCP pancreatitis (PEP) et al. Gut 2017;66:765–782. not preclude further investigation if clinical it is recommended that diclofenac or indomethacin Williams E, et al. Gut 2017;66:765–782. doi:10.1136/gutjnl-2016-312317 765 Downloaded from http://gut.bmj.com/ on May 23, 2017 - Published by group.bmj.com Guidelines (at a dose of 100 mg) should be administered rectally at the 2016 time of ERCP to all patients who do not have a contraindication It is recommended that, in patients undergoing laparoscopic to non-steroidal anti-inflammatory drugs (NSAIDs). cholecystectomy, transcystic or transductal laparoscopic bile (Moderate-quality evidence; strong recommendation) duct exploration (LBDE) is an appropriate technique for CBDS removal. There is no evidence of a difference in efficacy, mortal- New 2016 ity or morbidity when LBDE is compared with perioperative In patients with a high risk of PEP arising from repeated pancre- ERCP, although LBDE is associated with a shorter hospital stay. atic duct cannulation, insertion of a pancreatic stent is suggested It is recommended that the two approaches are considered in addition to administration of rectal NSAID. (Moderate- equally valid treatment options. (High-quality evidence; strong quality evidence; weak recommendation) recommendation) 2008, amended 2016 New 2016 It is recommended that patients undergoing biliary sphincterot- It is suggested that training of surgeons in LBDE is to be encour- omy for ductal stones have a full blood count (FBC) and inter- aged in order to decrease the number of interventions required to national normalised ratio or prothrombin time (INR/PT) manage CBDS. (Low-quality evidence; weak recommendation) performed prior to their ERCP.If deranged clotting or thrombo- fi cytopenia is identi ed, subsequent management should conform ‘ fi ’ to locally agreed guidelines. (Low-quality evidence; strong Management of dif cult ductal stones recommendation) New 2016 Laparoscopic duct exploration and ERCP (supplemented by New 2016 EPBD with prior sphincterotomy, mechanical lithotripsy or cho- It is recommended that ERCP patients taking warfarin, antipla- langioscopy where necessary) are highly successful in removing telet treatment or a direct oral anticoagulant (DOAC) should be CBDS. It is recommended that percutaneous radiological stone managed in accordance with the combined BSG and European extraction and open duct exploration should be reserved for the Society of Gastrointestinal Endoscopy (ESGE) guidelines for small number of patients in whom these techniques fail or are patients undergoing endoscopy. (Low-quality evidence; strong not possible. (Low-quality evidence; strong recommendation) recommendation) New 2016 2008, amended 2016 When endoscopic cannulation of the bile duct is not possible Competency in access papillotomy is suggested for all endosco- with standard techniques including access papillotomy, it is pists who perform ERCP. Training and subsequent mentorship recommended that percutaneous or EUS-guided procedures can should facilitate this. (Very low-quality evidence; weak be considered as a means of facilitating subsequent ERCP. (Low- recommendation) quality evidence; strong recommendation) New 2016 2016 As an adjunct to biliary sphincterotomy, endoscopic papillary It is important that endoscopists ensure adequate biliary drain- balloon dilation (EPBD) is recommended as a technique to age is achieved in patients with CBDS that have not been facilitate removal of large CBDS. (High-quality evidence; strong extracted. The short-term use of a biliary stent followed by recommendation) further endoscopy or surgery is recommended. (Moderate- quality evidence; strong recommendation) New 2016 EPBD without prior biliary sphincterotomy is associated with an 2016 increased risk of PEP but may be considered as an alternative to The use of a biliary stent as sole treatment for CBDS should be biliary sphincterotomy in selected patients, such as those with restricted to a selected group of patients with limited life expect- an uncorrected coagulopathy or difficult biliary access due to ancy and/or prohibitive surgical risk. (Moderate-quality evi- altered anatomy. If EPBD is performed without prior biliary dence; strong recommendation)
Recommended publications
  • Common Bile Duct Exploration
    Education Common Bile Duct Exploration What is a common bile duct exploration? The common bile duct is a tube that connects the liver, gallbladder, and pancreas to the small intestine. It helps deliver fluids for digestion. A common bile duct exploration is a procedure used to see if a stone is blocking the flow of bile from your liver and gallbladder to your intestine. When is it used? When a stone gets stuck in the common bile duct it may cause bile to back up into the liver. This causes jaundice. Jaundice is a condition in which the skin and the whites of the eyes become yellowish. If the stone is not removed, the common bile duct may become infected and need emergency surgery. It can also cause pancreatitis, a reaction in the pancreas that can be life threatening. Common bile duct exploration is often done during surgery to remove the gallbladder. An alternative procedure is an endoscopic retrograde cholangiopancreatography (ERCP). When an ERCP is done, a tube is inserted through your mouth and stomach into the small intestine. The tube can be used to put contrast dye into the duct to look for stones with x-rays. If there are stones, a small opening is made in the common duct to allow the stone or stones to pass into the intestine. You should ask your health care provider about these choices. How do I prepare for a common bile duct exploration? Plan for your care and recovery after the operation. Allow for time to rest and try to find people to help you with your day-to- day duties.
    [Show full text]
  • Bile Duct Cancer Causes, Risk Factors, and Prevention Risk Factors
    cancer.org | 1.800.227.2345 Bile Duct Cancer Causes, Risk Factors, and Prevention Risk Factors A risk factor is anything that affects your chance of getting a disease such as cancer. Learn more about the risk factors for bile duct cancer. ● Bile Duct Risk Factors ● What Causes Bile Duct Cancer? Prevention There's no way to completely prevent cancer. But there are things you can do that might help lower your risk. Learn more. ● Can Bile Duct Cancer Be Prevented? Bile Duct Risk Factors A risk factor is anything that affects your chance of getting a disease like cancer. Different cancers have different risk factors. Some risk factors, like smoking, can be changed. Others, like a person’s age or family history, can’t be changed. But having a risk factor, or even many risk factors, does not mean that a person will get 1 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 the disease. And many people who get the disease have few or no known risk factors. Researchers have found some risk factors that make a person more likely to develop bile duct cancer. Certain diseases of the liver or bile ducts People who have chronic (long-standing) inflammation of the bile ducts have an increased risk of developing bile duct cancer. Certain conditions of the liver or bile ducts can cause this, these include: ● Primary sclerosing cholangitis (PSC), a condition in which inflammation of the bile ducts (cholangitis) leads to the formation of scar tissue (sclerosis). People with PSC have an increased risk of bile duct cancer.
    [Show full text]
  • Nomina Histologica Veterinaria, First Edition
    NOMINA HISTOLOGICA VETERINARIA Submitted by the International Committee on Veterinary Histological Nomenclature (ICVHN) to the World Association of Veterinary Anatomists Published on the website of the World Association of Veterinary Anatomists www.wava-amav.org 2017 CONTENTS Introduction i Principles of term construction in N.H.V. iii Cytologia – Cytology 1 Textus epithelialis – Epithelial tissue 10 Textus connectivus – Connective tissue 13 Sanguis et Lympha – Blood and Lymph 17 Textus muscularis – Muscle tissue 19 Textus nervosus – Nerve tissue 20 Splanchnologia – Viscera 23 Systema digestorium – Digestive system 24 Systema respiratorium – Respiratory system 32 Systema urinarium – Urinary system 35 Organa genitalia masculina – Male genital system 38 Organa genitalia feminina – Female genital system 42 Systema endocrinum – Endocrine system 45 Systema cardiovasculare et lymphaticum [Angiologia] – Cardiovascular and lymphatic system 47 Systema nervosum – Nervous system 52 Receptores sensorii et Organa sensuum – Sensory receptors and Sense organs 58 Integumentum – Integument 64 INTRODUCTION The preparations leading to the publication of the present first edition of the Nomina Histologica Veterinaria has a long history spanning more than 50 years. Under the auspices of the World Association of Veterinary Anatomists (W.A.V.A.), the International Committee on Veterinary Anatomical Nomenclature (I.C.V.A.N.) appointed in Giessen, 1965, a Subcommittee on Histology and Embryology which started a working relation with the Subcommittee on Histology of the former International Anatomical Nomenclature Committee. In Mexico City, 1971, this Subcommittee presented a document entitled Nomina Histologica Veterinaria: A Working Draft as a basis for the continued work of the newly-appointed Subcommittee on Histological Nomenclature. This resulted in the editing of the Nomina Histologica Veterinaria: A Working Draft II (Toulouse, 1974), followed by preparations for publication of a Nomina Histologica Veterinaria.
    [Show full text]
  • What Are the Risk Factors for Acute Suppurative Cholangitis Caused by Common Bile Duct Stones?
    Gut and Liver, Vol. 4, No. 3, September 2010, pp. 363-367 original article What Are the Risk Factors for Acute Suppurative Cholangitis Caused by Common Bile Duct Stones? Dong Han Yeom, Hyo Jeong Oh, Young Woo Son, and Tae Hyeon Kim Department of Internal Medicine, Wonkwang University School of Medicine, Iksan, Korea Background/Aims: Acute suppurative cholangitis (ASC), INTRODUCTION a severe form of acute cholangitis, is a life-threat- ening condition that must be treated with appropriate Acute cholangitis ranges from mild forms that respond and timely management. The purpose of this study to medical therapy to severe forms that lead to septice- was to identify the factors that predispose patients to mia, a potentially lethal condition requiring urgent drain- ASC. Methods: We retrospectively investigated 181 1,2 age of the biliary system. Acute suppurative cholangitis patients (100 men, 81 women; age, 70.66±7.38 years, (ASC) refers to the presence of pus in the bile ducts. The mean±SD) who were admitted to Wonkwang Univer- accumulation of pus in a bile duct may cause increased sity Hospital between January 2005 and June 2007 for acute cholangitis with common bile duct (CBD) intrabiliary pressure, which can lead to biliary sepsis. stones. All patients underwent endoscopic retrograde Urgent medical or surgical decompression of the bile duct 3 cholangiopancreatogram to remove the stones. should be performed in patients with ASC. Formerly, the Variables and factors that could be assessed upon management of this life-threatening condition was urgent admission were analyzed to identify the risk factors surgical biliary decompression; however, this treatment for the development of ASC.
    [Show full text]
  • Updated Guideline on the Management of Common Bile Duct Stones
    Guidelines Updated guideline on the management of common Gut: first published as 10.1136/gutjnl-2016-312317 on 25 January 2017. Downloaded from bile duct stones (CBDS) Earl Williams,1 Ian Beckingham,2 Ghassan El Sayed,1 Kurinchi Gurusamy,3 Richard Sturgess,4 George Webster,5 Tudor Young6 1Bournemouth Digestive ABSTRACT suspicion remains high. (Low-quality evidence; Diseases Centre, Royal Common bile duct stones (CBDS) are estimated to be strong recommendation) Bournemouth and Christchurch – NHS Hospital Trust, present in 10 20% of individuals with symptomatic Bournemouth, UK gallstones. They can result in a number of health New 2016 2HPB Service, Nottingham problems, including pain, jaundice, infection and acute Magnetic resonance cholangiopancreatography University Hospitals NHS Trust, pancreatitis. A variety of imaging modalities can be (MRCP) and endoscopic ultrasound (EUS) are both Nottingham, UK 3 employed to identify the condition, while management recommended as highly accurate tests for identifying Department of Surgery, fi University College London of con rmed cases of CBDS may involve endoscopic CBDS among patients with an intermediate probabil- Medical School, London, UK retrograde cholangiopancreatography, surgery and ity of disease. MRCP predominates in this role, with 4Aintree Digestive Diseases radiological methods of stone extraction. Clinicians are choice between the two modalities determined by Unit, Aintree University Hospital therefore confronted with a number of potentially valid individual suitability, availability of the relevant test, Liverpool, Liverpool, UK 5Department of options to diagnose and treat individuals with suspected local expertise and patient acceptability. (Moderate Hepatopancreatobiliary CBDS. The British Society of Gastroenterology first quality evidence; strong recommendation) Medicine, University College published a guideline on the management of CBDS in Hospital, London, UK 2008.
    [Show full text]
  • Impacted Common Bile Duct Stone Managed by Hepaticoduodenostomy
    Impacted common bile duct stone managed by hepaticoduodenostomy: a case report. Elroy Weledji1, Ndiformuche Mbengawoh2, and Frank Zouna1 1University of Buea 2Limbe Regional Hospital October 5, 2020 Abstract We present herein a hepaticoduodenotomy performed for a retained, impacted distal CBD stone in a low resource setting with a good outcome. This impacted stone had complicated an open cholecystectomy for acute cholecystitis by causing the dehiscence of the cystic duct stump as a result of distal biliary obstruction. Key Clinical message A bypass procedure such as a hepaticoduodenotomy may be an alternative to the traditional choledochoduo- denostomy in the management of the retained, impacted distal CBD stone especially in the presence of sepsis. Introduction The management of common bile duct (CBD) stones is well established. An algorithm showing the available strategies for the management of CBD stones following a routine or selective per-operative cholangiogram or a pre-operative endoscopic retrograde cholangiopancreatogram is illustrated in figure 1[1]. Although the laparoscopic exploration for CBD stones has gained grounds over endoscopic retrograde cholangiography ( ERCP) and sphincterotomy and duct clearance, there is no consensus as to the ideal approach [2, 3]. The management strategy chosen will depend on personal experience, equipment availability, time and the availability of other departmental expertise [3]. For a distally impacted CBD stone in a low resource setting, an open approach will entail either leaving the stone where it is and carry out a choledochoduodenostomy, or removing the stone through a transduodenal sphincteroplasty [4]. We present herein a hepaticoduodenostomy performed for an impacted distal CBD stone. This retained and impacted stone had complicated an open cholecystectomy for acute cholecystitis by causing biliary leakage from the dehisced ligated cystic duct stump due to back pressure of bile.
    [Show full text]
  • Biliary Strictures in Primary Sclerosing Cholangitis
    From Department of Medicine, Huddinge Karolinska Institutet, Stockholm, Sweden BILIARY STRICTURES IN PRIMARY SCLEROSING CHOLANGITIS ASPECTS ON INFLAMMATION AND MALIGNANCY Erik von Seth Stockholm 2018 Front picture by Urban Arnelo All previously published papers were reproduced with permission from the publisher. Published by Karolinska Institutet. Printed by Eprint © Erik von Seth, 2018 ISBN 978-91-7831-048-7 Biliary strictures in primary sclerosing cholangitis – aspects on inflammation and malignancy THESIS FOR DOCTORAL DEGREE (Ph.D.) By Erik von Seth Principal Supervisor: Opponent: Annika Bergquist Bertus Eksteen Karolinska Institutet University of Calgary Department of Medicine Huddinge Department of Medicine Division of Gastroenterology and Rheumatology Division of Gastroenterology Co-supervisor(s): Examination Board: Urban Arnelo Marie Carlson Karolinska Institutet Uppsala University Department of Clinical Science, Intervention and Department of Medical Sciences Technology (CLINTEC) Division of Gastroenterology Division of Surgery Marianne Udd Stephan Haas University of Helsinki Karolinska Institutet Department of Surgery Department of Medicine Huddinge Division of Gastroenterology and Rheumatology Jonas Halfvarson Örebro University Niklas Björkström School of Medical Sciences Karolinska Institutet Department of Gastroenterology Department of Medicine Huddinge Center for Infectious Medicine “Livet kan/får inte vara en kompromiss på en gång sant och falskt men kan inte levas utan kompromiss ergo sant och falskt 3,99999 är en god approximation för 2X2” Gunnar Ekelöf ABSTRACT Primary sclerosing cholangitis (PSC) is a rare liver disease that is characterized by chronic inflammation of bile ducts with development of fibrosis and strictures. The pathogenic mechanisms involved in this disease are insufficiently understood. PSC is associated with a high risk of cholangiocarcinoma (CCA), lifetime prevalence is estimated to approximately 10%.
    [Show full text]
  • Cystic Duct Cholangiography Leo Chaikof
    Henry Ford Hospital Medical Journal Volume 22 Number 3 Laurence S. Fallis, M.D. Commemorative Article 7 Issue 9-1974 Cystic Duct Cholangiography Leo Chaikof T. L. Friedlich R. A. Affifi H. Weizel Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health Commons Recommended Citation Chaikof, Leo; Friedlich, T. L.; Affifi, R. A.; and Weizel, H. (1974) "Cystic Duct Cholangiography," Henry Ford Hospital Medical Journal : Vol. 22 : No. 3 , 129-136. Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol22/iss3/7 This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has been accepted for inclusion in Henry Ford Hospital Medical Journal by an authorized editor of Henry Ford Health System Scholarly Commons. Henry Ford Hosp. Med. Journal Vol. 22, No. 3, 1974 Cystic Duct Cholangiography Leo Chaikof, MD,* T.L. Friedlich, MD, R.A. Affifi, MD and H. Weizel, MD ALTHOUGH operative cholangiog­ raphy was first used in 1932 by Mirizzi,^'^ it is still not done routinely as part of the surgical procedure in biliary tract opera­ tions. According to Jolly, Baker et al,^ only 18% of members of the American Surgical Association use it routinely. De­ spite a great deal of discussion pro and con in the literature,^'" it appears that, if A series of 837 cystic duct cholangiograms the frequency of common duct explora­ has been reviewed. The technique is simple and safe to carry out. It is not time consuming tion can be reduced, certainly its as­ and does not require any unusual equipment.
    [Show full text]
  • Pancreaticobiliary Ductal Union Gut: First Published As 10.1136/Gut.31.10.1144 on 1 October 1990
    1144 Gut, 1990, 31, 1144-1149 Pancreaticobiliary ductal union Gut: first published as 10.1136/gut.31.10.1144 on 1 October 1990. Downloaded from S P Misra, M Dwivedi Abstract TABLE ii Length ofthe common channel in normalsubjects in The main pancreatic duct and the common bile various series duct open into the second part of the duo- Authors Mean (mm) Range (mm) denum alone or after joining as a common Misra et al4 4-7 1-018-4 channel. A common channel of >15 mm (an Kimura et al5 4.6 2-10 anomalous pancreaticobiliary duct) is associ- Dowdy et al6 4-4 1-12 ated with congenital cystic dilatation of the common bile duct and carcinoma of the gall bladder. Even a long common channel channel of <3 mm, and 18% had a common (38 mm) is associated with a higher frequency channel of >3 mm. The rhean length was not of carcinoma of the gall bladder. Gail stones mentioned.2 In a necropsy study of 35 infants, smaller than the common channel and a long Miyano et al' noted that the average length of the common channel predispose to gail stone common channel was 1 3 mm. induced acute pancreatitis. Separate openings Kimura et al,' using cineradiography during for the two ductal systems predisposes to ERCP, have shown contractile motility of the development of gall stones and alcohol ductal wall extending well beyond the common induced chronic pancreatitis. The role of channel, towards the liver. The mean (SD) ductal union has also been investigated in length of the contractile segment was 20 5 primary sclerosing cholangitis and biliary (4 6) mm (range 14-31 mm).
    [Show full text]
  • What Is the Normal Size of the Common Bile Duct?
    DOI: https://doi.org/10.22516/25007440.136 Original articles What is the normal size of the common bile duct? Martín Alonso Gómez Zuleta, MD,1 Óscar Fernando Ruiz Morales, MD,2 William Otero Regino, MD.3 1 Internist and Gastroenterologist, Professor at the Abstract National University of Colombia. Gastroenterologist at National University of Colombia Hospital in Traditionally, the common bile duct (CBD) has been said to measure up to 6 mm in patients with gallbladders Bogotá, Colombia and up to 8 mm in cholecystectomized patients. However, these recommendations are based on very old 2 Internist and Gastroenterologist at Hospital Nacional studies performed with trans-abdominal ultrasound. Echoendoscopy has greater sensitivity and specificity for Universitario and Kennedy Hospital in Bogotá, Colombia evaluating the bile duct, but studies had not yet been done in our population to evaluate the normal size of 3 Internist and Gastroenterologist, Professor of the CBD by this method. Gastroenterology at the National University of Objective: The objective of this study was to evaluate the size of the CBD in patients with gallbladders and Colombia in Bogotá, Colombia patients without gallbladders. Materials and Methods: This is a prospective descriptive study of patients who underwent echoendoscopy ......................................... at the gastroenterology unit in the El Tunal hospital, Universidad Nacional de Colombia. Patients had been Received: 05-11-15 Accepted: 21-04-17 referred for diagnostic echoendoscopy to evaluate subepithelial lesions in the esophagus and/or stomach. Once the lesion had been evaluated and an echoendoscopic diagnosis had been established, the transducer was advanced to the second duodenal portion to perform bilio-pancreatic echoendoscopy.
    [Show full text]
  • Chronic Pancreatitis: Introduction
    Chronic Pancreatitis: Introduction Authors: Anthony N. Kalloo, MD; Lynn Norwitz, BS; Charles J. Yeo, MD Chronic pancreatitis is a relatively rare disorder occurring in about 20 per 100,000 population. The disease is progressive with persistent inflammation leading to damage and/or destruction of the pancreas . Endocrine and exocrine functional impairment results from the irreversible pancreatic injury. The pancreas is located deep in the retroperitoneal space of the upper part of the abdomen (Figure 1). It is almost completely covered by the stomach and duodenum . This elongated gland (12–20 cm in the adult) has a lobe-like structure. Variation in shape and exact body location is common. In most people, the larger part of the gland's head is located to the right of the spine or directly over the spinal column and extends to the spleen . The pancreas has both exocrine and endocrine functions. In its exocrine capacity, the acinar cells produce digestive juices, which are secreted into the intestine and are essential in the breakdown and metabolism of proteins, fats and carbohydrates. In its endocrine function capacity, the pancreas also produces insulin and glucagon , which are secreted into the blood to regulate glucose levels. Figure 1. Location of the pancreas in the body. What is Chronic Pancreatitis? Chronic pancreatitis is characterized by inflammatory changes of the pancreas involving some or all of the following: fibrosis, calcification, pancreatic ductal inflammation, and pancreatic stone formation (Figure 2). Although autopsies indicate that there is a 0.5–5% incidence of pancreatitis, the true prevalence is unknown. In recent years, there have been several attempts to classify chronic pancreatitis, but these have met with difficulty for several reasons.
    [Show full text]
  • Primary Sclerosing Cholangitis: Introduction
    Primary Sclerosing Cholangitis: Introduction Primary sclerosing cholangitis (PSC) is a chronic , usually progressive, stricturing disease of the biliary tree. Remissions and relapses characterize the disease course. Primary sclerosing cholangitis may remain quiescent for long periods of time in some patients; in most cases, however, it is progressive. The prevalence of primary sclerosing cholangitis in the United States is approximately 1–6 cases per 100,000 population. Most patients with primary sclerosing cholangitis are men (75%) with an average age of approximately 40 years at diagnosis. The overwhelming majority of patients affected with primary sclerosing cholangitis are Caucasian. The etiology is unknown but current opinion favors an immune cause. Management of this disease in the early stages involves the use of drugs to prevent disease progression. Endoscopic and surgical approaches are reserved for the time when symptoms develop. Liver transplantation may ultimately be required and offers the only chance for a complete cure. Patients with primary sclerosing cholangitis are at an increased risk for cholangiocarcinoma (10–15%). Figure 1. Location of the biliary tree in the body. What is PSC? Primary sclerosing cholangitis is a chronic fibrosing inflammatory process that results in the obliteration of the biliary tree and biliary cirrhosis. There is variability in the extent of involvement of the biliary system. The majority of patients with primary sclerosing cholangitis have underlying inflammatory bowel disease, namely ulcerative colitis or Crohn’s disease. Patients with primary sclerosing cholangitis are more likely to have ulcerative colitis than Crohn’s disease (85% versus 15%), with approximately 2.5–7.5% of all ulcerative colitis patients having primary sclerosing cholangitis.
    [Show full text]